SK282061B6 - Makrolidy, spôsob ich prípravy a farmaceutický prostriedok - Google Patents
Makrolidy, spôsob ich prípravy a farmaceutický prostriedok Download PDFInfo
- Publication number
- SK282061B6 SK282061B6 SK435-93A SK43593A SK282061B6 SK 282061 B6 SK282061 B6 SK 282061B6 SK 43593 A SK43593 A SK 43593A SK 282061 B6 SK282061 B6 SK 282061B6
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- hydroxy
- formula
- compounds
- iii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929209815A GB9209815D0 (en) | 1992-05-07 | 1992-05-07 | Organic compounds,processes for their production and their use |
GB939304927A GB9304927D0 (en) | 1993-03-10 | 1993-03-10 | Organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
SK43593A3 SK43593A3 (en) | 1995-07-11 |
SK282061B6 true SK282061B6 (sk) | 2001-10-08 |
Family
ID=26300836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK435-93A SK282061B6 (sk) | 1992-05-07 | 1993-05-05 | Makrolidy, spôsob ich prípravy a farmaceutický prostriedok |
Country Status (25)
Country | Link |
---|---|
US (1) | US5514685A (de) |
EP (1) | EP0569337B1 (de) |
JP (1) | JP2788392B2 (de) |
KR (1) | KR100292311B1 (de) |
CN (1) | CN1037773C (de) |
AT (1) | ATE155787T1 (de) |
AU (1) | AU668152B2 (de) |
CA (1) | CA2095659C (de) |
CY (1) | CY2126B1 (de) |
CZ (1) | CZ291773B6 (de) |
DE (1) | DE69312386T2 (de) |
DK (1) | DK0569337T3 (de) |
ES (1) | ES2105193T3 (de) |
FI (2) | FI102612B (de) |
GR (1) | GR3024754T3 (de) |
HU (2) | HUT66531A (de) |
IL (1) | IL105607A (de) |
MY (1) | MY109602A (de) |
NO (1) | NO305865B1 (de) |
NZ (1) | NZ247553A (de) |
PH (1) | PH30456A (de) |
RU (1) | RU2126009C1 (de) |
SG (1) | SG47011A1 (de) |
SK (1) | SK282061B6 (de) |
TW (1) | TW330936B (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY110603A (en) * | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
JP4155593B2 (ja) | 1994-10-26 | 2008-09-24 | ノバルティス・アクチエンゲゼルシャフト | 医薬組成物 |
MY129435A (en) | 1994-10-26 | 2007-04-30 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
PT2198858E (pt) | 1998-03-26 | 2011-09-01 | Astellas Pharma Inc | Composição farmacêutica de libertação constante que contém um macrólido como o tacrolimus |
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
US7063857B1 (en) | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
GB0008785D0 (en) | 2000-04-10 | 2000-05-31 | Novartis Ag | Organic compounds |
CA2492989C (en) | 2002-07-23 | 2012-11-20 | Novartis Ag | Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
KR100469917B1 (ko) * | 2002-09-09 | 2005-02-02 | (주)조은식품 | 구수한 호박씨가 첨가된 호박엿 및 그 제조방법 |
KR100745493B1 (ko) * | 2005-12-16 | 2007-08-03 | 주식회사농심 | 조직감이 향상된 사출 스낵 및 그 제조 방법 |
US8716293B2 (en) * | 2010-04-02 | 2014-05-06 | Janssen R&D Ireland | Macrocyclic integrase inhibitors |
ES2898849T3 (es) | 2014-10-28 | 2022-03-09 | Koushi Yamaguchi | Medicamento para mejorar el síndrome de hipertensión inducida por el embarazo |
JP7465806B2 (ja) | 2018-08-10 | 2024-04-11 | 晃史 山口 | 母体と胎児との関係における液性免疫関連疾患の治療薬 |
WO2020129348A1 (ja) | 2018-12-18 | 2020-06-25 | 晃史 山口 | 不妊・不育症または妊娠状態を改善するための薬剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
US5254562A (en) * | 1984-12-03 | 1993-10-19 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
CA1316916C (en) * | 1988-10-12 | 1993-04-27 | David Askin | Hydroxide mediated fk-506 rearrangement product |
EP0364031B1 (de) * | 1988-10-12 | 1992-12-23 | Merck & Co. Inc. | Verfahren zur Umlagerung von FK-506 unter Beteiligung von Hydroxid |
KR920700212A (ko) * | 1989-06-14 | 1992-02-19 | 쟝 크라머·한스 루돌프 하우스 | 헤테로원자-함유 트리사이클릭 화합물 |
EP0413532A3 (en) * | 1989-08-18 | 1991-05-15 | Fisons Plc | Macrocyclic compounds |
IE904050A1 (en) * | 1989-11-13 | 1991-05-22 | Merck & Co Inc | Aminomacrolides and derivatives having immunosuppressive¹activity |
US5260301A (en) * | 1990-03-01 | 1993-11-09 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical solution containing FK-506 |
GB2246350A (en) * | 1990-07-23 | 1992-01-29 | Fujisawa Pharmaceutical Co | Tricyclo compounds |
EP0480623A1 (de) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | Halomakrolide und Derivate mit immunosuppressiver Wirkung |
WO1992013862A1 (en) * | 1991-02-05 | 1992-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Lactone compounds |
JPH06510304A (ja) * | 1991-09-05 | 1994-11-17 | アボツト・ラボラトリーズ | 大環状イムノモジュレーター |
-
1993
- 1993-04-22 HU HU9301190A patent/HUT66531A/hu unknown
- 1993-05-04 SG SG1996001883A patent/SG47011A1/en unknown
- 1993-05-04 ES ES93810325T patent/ES2105193T3/es not_active Expired - Lifetime
- 1993-05-04 AT AT93810325T patent/ATE155787T1/de not_active IP Right Cessation
- 1993-05-04 EP EP93810325A patent/EP0569337B1/de not_active Expired - Lifetime
- 1993-05-04 DK DK93810325.6T patent/DK0569337T3/da active
- 1993-05-04 DE DE69312386T patent/DE69312386T2/de not_active Expired - Lifetime
- 1993-05-05 CZ CZ1993829A patent/CZ291773B6/cs not_active IP Right Cessation
- 1993-05-05 NO NO931627A patent/NO305865B1/no not_active IP Right Cessation
- 1993-05-05 MY MYPI93000847A patent/MY109602A/en unknown
- 1993-05-05 NZ NZ247553A patent/NZ247553A/en not_active IP Right Cessation
- 1993-05-05 IL IL105607A patent/IL105607A/en not_active IP Right Cessation
- 1993-05-05 FI FI932035A patent/FI102612B/fi not_active IP Right Cessation
- 1993-05-05 SK SK435-93A patent/SK282061B6/sk not_active IP Right Cessation
- 1993-05-05 PH PH46144A patent/PH30456A/en unknown
- 1993-05-06 AU AU38393/93A patent/AU668152B2/en not_active Ceased
- 1993-05-06 JP JP5105392A patent/JP2788392B2/ja not_active Expired - Fee Related
- 1993-05-06 CN CN93106551A patent/CN1037773C/zh not_active Expired - Fee Related
- 1993-05-06 KR KR1019930007766A patent/KR100292311B1/ko not_active IP Right Cessation
- 1993-05-06 CA CA002095659A patent/CA2095659C/en not_active Expired - Fee Related
- 1993-05-06 RU RU93005029A patent/RU2126009C1/ru not_active IP Right Cessation
- 1993-05-08 TW TW082103599A patent/TW330936B/zh not_active IP Right Cessation
-
1995
- 1995-05-15 US US08/441,492 patent/US5514685A/en not_active Expired - Lifetime
- 1995-06-19 HU HU95P/P00246P patent/HU211135A9/hu unknown
-
1997
- 1997-09-17 GR GR970402399T patent/GR3024754T3/el unknown
-
1998
- 1998-11-16 FI FI982476A patent/FI982476A0/fi unknown
-
1999
- 1999-02-03 CY CY9900004A patent/CY2126B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69021833T2 (de) | Heteroatome enthaltende tricyclische Verbindungen. | |
DE69333577T2 (de) | Rapamycin-Derivate und ihre Verwendung, insbesondere als Immunosuppressoren | |
SK282061B6 (sk) | Makrolidy, spôsob ich prípravy a farmaceutický prostriedok | |
DE60309909T2 (de) | Glucocorticoidrezeptorliganden zur behandlung von stoffwechselstörungen | |
AU683463B2 (en) | New prednisolone derivates | |
HUT73418A (en) | Process for preparing rapamycin carbonate esters and pharmaceutical compositions of immunosuppressive activity containing said compounds | |
RU2130460C1 (ru) | Производные тетрагидропирана и фармацевтическая композиция на их основе | |
EP0402931A1 (de) | Heteroatome enthaltende tricyclische Verbindungen | |
EP2512485A1 (de) | Neuartige pgp-steroidhemmer zur verwendung als hemmer von multidrug-resistenz | |
JPH04230388A (ja) | ヘテロ原子含有三環式化合物 | |
US5266566A (en) | Method of treating fungal infections using sterodial ester compounds | |
DE69901907T2 (de) | Fotocyclisierte rapamycine | |
KR100317009B1 (ko) | 테트라하이드로피란유도체 | |
PL173506B1 (pl) | Związki tricykliczne zawierające heteroatomy | |
DE19963266A1 (de) | Steroidale Hemmstoffe der Lp(a)-Biosynthese | |
PL176409B1 (pl) | Pochodne tetrahydropiranu, sposób ich wytwarzania i zawierająca je kompozycja farmaceutyczna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20110505 |